RCA
ELAN icon

Resonant Capital Advisors’s Elanco Animal Health ELAN Stock Holding History

Resonant Capital Advisors’s Portfolio ELAN Stock Details ELAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$773K Sell
31,426
-466
-1% -$10.8K 0.04% 224
2026
Q1 		$763K Buy
31,892
+139
+0.4% +$3.4K 0.04% 206
2025
Q4 		$719K Sell
31,753
-1,070
-3% -$23.3K 0.04% 200
2025
Q3 		$661K Buy
32,823
+1,090
+3% +$18.3K 0.04% 209
2025
Q2 		$453K Buy
31,733
+2,319
+8% +$27.1K 0.03% 251
2025
Q1 		$309K Buy
29,414
+1,576
+6% +$17.8K 0.02% 280
2024
Q4 		$337K Buy
27,838
+266
+1% +$3.48K 0.02% 251
2024
Q3 		$405K Buy
27,572
+247
+0.9% +$3.44K 0.03% 227
2024
Q2 		$394K Buy
27,325
+1,306
+5% +$20.9K 0.03% 224
2024
Q1 		$424K Buy
26,019
+230
+0.9% +$3.6K 0.04% 217
2023
Q4 		$384K Buy
25,789
+4,172
+19% +$47.3K 0.04% 206
2023
Q3 		$243K Buy
21,617
+833
+4% +$9.67K 0.03% 241
2023
Q2 		$209K Buy
20,784
+1,028
+5% +$9.54K 0.02% 258
2023
Q1 		$186K Buy
19,756
+432
+2% +$5.1K 0.02% 248
2022
Q4 		$236K Buy
+19,324
New +$241K 0.03% 233
2022
Q2 		– Sell
-14,294
Closed -$373K – 240
2022
Q1 		$373K Buy
14,294
+614
+4% +$16.4K 0.06% 165
2021
Q4 		$388K Buy
13,680
+1,174
+9% +$36.5K 0.06% 153
2021
Q3 		$399K Buy
12,506
+2,266
+22% +$76K 0.07% 145
2021
Q2 		$355K Buy
10,240
+275
+3% +$9.07K 0.07% 143
2021
Q1 		$293K Buy
9,965
+130
+1% +$4K 0.06% 151
2020
Q4 		$302K Buy
9,835
+422
+4% +$12.9K 0.07% 149
2020
Q3 		$263K Sell
9,413
-1,530
-14% -$38.8K 0.08% 138
2020
Q2 		$235K Sell
10,943
-5,534
-34% -$122K 0.07% 163
2020
Q1 		$369K Buy
16,477
+1,096
+7% +$30K 0.13% 147
2019
Q4 		$453K Buy
+15,381
New +$418K 0.14% 152

Other funds holding ELAN

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $29.1B AUM 43.86% 1-Year Est. Return

Resonant Capital Advisors's ELAN Position: Q2 2026 in Review

Resonant Capital Advisors reduced its Elanco Animal Health (ELAN) stake by 1.5% in Q2 2026, selling an estimated $10.8K and leaving 31,426 shares worth $773K. The position accounts for 0.04% of the portfolio, ranked #224.

Resonant Capital Advisors first reported a position in ELAN in Q4 2019 and has held it in 25 quarters since. 522 funds tracked by Wall St. Rank hold ELAN as of Q2 2026.

  • Resonant Capital Advisors held 31,426 shares of Elanco Animal Health worth $773K as of Q2 2026.
  • Resonant Capital Advisors sold 466 Elanco Animal Health shares in Q2 2026, an estimated $10.8K.
  • Elanco Animal Health made up 0.04% of Resonant Capital Advisors's portfolio in Q2 2026, its #224 holding.
  • Resonant Capital Advisors first reported a position in Elanco Animal Health in Q4 2019 and has held it in 25 quarters since.
  • 522 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2026.

Based on Resonant Capital Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.